Medical Plastics Ltd. recently welcomed a delegation from the National Agency for Food and Drug Administration and Control (NAFDAC) to its syringe manufacturing facility. This visit underscores the vital collaboration between the regulatory body and Medical Plastics Ltd., reinforcing our commitment to meeting and exceeding the required standards for medical device manufacturing in Nigeria.

The NAFDAC team toured the state-of-the-art facility, inspecting our advanced production processes and reviewing the stringent Good Manufacturing Practices (GMP) we have in place. A key highlight of the visit was the demonstration of our cutting-edge E-Beam Sterilization technology, which guarantees the safety and sterility of our syringes, ensuring they meet the highest standards of quality and reliability.

In addition to the facility tour, the visit provided an opportunity to engage in discussions about our plans for expanding production and our ongoing commitment to quality assurance. We shared our vision for scaling up operations to meet the increasing demand for safe and reliable medical supplies, both locally and regionally.

A spokesperson from Medical Plastics Ltd. noted, “The visit by NAFDAC is a testament to our dedication to maintaining the highest levels of safety and quality in our products. This collaboration with the regulatory authority ensures that we continue to operate in line with best practices and industry standards, contributing to the improvement of healthcare delivery in Nigeria.”

The successful visit reflects Medical Plastics Ltd.’s ongoing efforts to support Nigeria’s healthcare infrastructure by providing essential medical devices that adhere to national and international quality standards. As a trusted manufacturer, we remain committed to driving innovation and excellence in the medical supplies sector.